We are proud to announce our partnership with GenomOncology and Belay Diagnostics to accelerate clinical trial enrollment for CNS cancer patients. Through our partnership, users can move directly from genomic reports to the WeTrials platform to access a patient-friendly, simplified clinical trial interface aligned with a patient’s biomarker profile and pursue enrollment through a streamlined process. In this way, molecular insights lead to meaningful treatment opportunities—helping connect patients to innovative therapies and trials, while giving clinicians a seamless on-ramp to patient enrollment directly within their workflow. @Belay_Dx@genomoncology@DrAMansouri
On World Brain Tumor Day, we recognize the patients and caregivers navigating diagnosis, treatment decisions, and the search for clear, reliable information.
A brain tumor diagnosis can bring urgent questions: What does this diagnosis mean? What support is available? Are clinical trials an option? Where should patients and caregivers begin?
WeTrials helps bring brain tumor resources into one place, including clinical trial information, support resources, and patient education tools, so patients and caregivers can better understand their options and move forward with clarity.
Take action today:
1. Visit the WeTrials Brain Cancer Resource Page
2. Watch Caregiver Chronicles, presented by Janet Fanaki. Hosted by Janet Fanaki, a former caregiver and advocate, the series features practical advice tailored to families navigating complex neurological diagnoses.
Access both resources through our Linktree at linktree.com/wetrials or through the link in bio.
#WorldBrainTumorDay#BrainTumorAwareness#BrainCancerAwareness#WeTrials#ClinicalTrials#CaregiverSupport#PatientEducation
Clinical trials can open the door to more treatment options, but many patients and caregivers may not know these options exist.
WeTrials helps make clinical trials, support resources, and educational content easier to explore across breast, brain, lung, pediatric, and prostate cancers. Learn more and explore options with clarity and confidence.
Explore options at WeTrials.com/patients
Clinical trials can open the door to options beyond the standard of care, but they are not always discussed early.
This Clinical Trials Awareness Month, ask early, explore your options, and learn how participation can help shape future cancer care.
Explore clinical trial options for free: wetrials.com#ClinicalTrials#Cancer
Cancer disparities are shaped by more than treatment alone. Trust, access, and education all play a role. Reaching underserved communities in familiar spaces, rather than expecting patients to navigate intimidating systems on their own, can make a real difference.
Community-based outreach helps break myths, build trust, and make clinical trial information more accessible to the people who need it most.
#HealthEquity#CancerDisparities#ClinicalTrials#PatientEducation#CommunityOutreach#UnderservedCommunities#MinorityHealthMonth#WeTrials
AYA Cancer Awareness Month is a reminder that cancer in young people can take many different forms. Across ages 15–39, the most common diagnoses shift, symptoms can be easier to dismiss, and access to age-appropriate care and clinical trials is still uneven. Young people deserve earlier answers, better support, and care that reflects the reality of this stage of life.
Swipe through for a closer look at the cancers affecting adolescents and young adults, why some red flags are easier to miss, and why awareness matters. Share this with someone in their teens, 20s, or 30s — or someone who loves them.
For anyone trying to make sense of next steps, WeTrials offers tools to help patients and caregivers explore clinical trials and find support resources with more clarity and confidence. Visit wetrials.com/patients to learn more.
#AYACancerAwarenessMonth#AYACancer#YoungAdultCancer#AdolescentCancer#CancerAwareness#ClinicalTrials#CancerSupport#CancerEducation#OncologyAwareness#Wetrials
ALT Adolescent Cancer & Young Adult Awareness Month
A prostate cancer diagnosis can bring a wave of questions, but you don't have to navigate it in the dark. Understanding your condition is the first step to confident, personalized care.
Swipe through our latest guide to learn about:
🩺 The Signs: How to spot early urinary symptoms and when to get tested.
🧬 Your Options: Why care isn't "one-size-fits-all" (ranging from active surveillance to advanced therapies).
🤝 Taking Control: Why pausing for a second expert opinion before starting treatment can change your entire care plan.
Knowledge is power. Equip yourself with the facts and explore all your avenues.
Get Started Today — Completely FREE. Discover advanced treatments and support resources on our Prostate Cancer Resource Page: wetrials.com/patients/prosta…
Breast cancer can be an overwhelming topic, but understanding the basics makes it a little less scary. 🎗️
Remember: not all changes mean cancer, but it is always best to get them checked by a doctor.
Get Started Today — Completely FREE. Discover advanced treatments and support resources on our Breast Cancer Resource Page: f.mtr.cool/bsutatkzoo (or tap the link in our bio!).
Our Phase 0/1b clinical trial of AZD1390 is now open for patients with newly diagnosed grade 4 glioma. If you or someone you know has this diagnosis, you can contact our Ivy Navigators today to determine eligibility.
🌐 bar.rw/3Mefjq3
☎️: 602-406-8605
✉️: Research@IvyBrainTumorCenter.org
A newly activated Phase 0/1 study at the Ivy Brain Tumor Center is evaluating risvutatug rezetecan (Ris-Rez), a B7-H3–targeted antibody–drug conjugate, through pharmacokinetic and pharmacodynamic analyses in recurrent grade 4 glioma and brain metastases.
More on our website:
🌐 bar.rw/4rH2X97